Molecular genetic of human male infertility: From genes to new therapeutic perspectives

Current Pharmaceutical Design

Volumn 10, Issue 5, 2004, Pages 471-500

  Vogt, Peter H ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE   (Germany)

Author keywords

Androgen receptor; AZF locus; CF CBAVD locus; Chromosome aneuploidies; Cryptorchidism; Genetic load factor; Idiopathic hypergonadotropic hypogonadism; Imprinting; Kartagener; Klinefelter

Indexed keywords

ANDROGEN RECEPTOR; DNA DIRECTED DNA POLYMERASE GAMMA; LUTEINIZING HORMONE RECEPTOR; MITOCHONDRIAL DNA;

ANEUPLOIDY; CHROMATIN CONDENSATION; CHROMOSOME REARRANGEMENT; CLINICAL PROTOCOL; DISEASE ASSOCIATION; FERTILIZATION IN VITRO; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GERM LINE; GONAD DEVELOPMENT; HERITABILITY; HORMONE SUBSTITUTION; HUMAN; INFERTILITY THERAPY; KALLMANN SYNDROME; KNOCKOUT GENE; MALE; MALE INFERTILITY; MARKER GENE; MEDICAL RESEARCH; MOUSE; MULTIGENE FAMILY; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PATHOGENESIS; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; STRUCTURAL CHROMOSOME ABERRATION; Y CHROMOSOME; ANIMAL; GENE THERAPY; GENETIC MARKER; GENETICS; METABOLISM; METHODOLOGY;

ANIMALS; GENE THERAPY; GENETIC MARKERS; HUMANS; INFERTILITY, MALE; MALE;

EID: 1042268863     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043453261     Document Type: Review

References (252)

1. World Health Organisation. Towards more objectivity in diagnosis and management of male infertility. Int J Andrology 1987; 7: 1-35.
2. Hackstein JH, Hochstenbach R, Pearson PL. Towards an understanding of the genetics of human male infertility: lessons from flies. Trends Genet 2000; 16: 565-572.
3. Cooke HJ, Saunders PT. Mouse models of male infertility. Nat Rev Genet 2002; 3: 790-801.
4. Matzuk MM, Lamb DJ. Genetic dissection of mammalian fertility pathways. Nat Cell Biol 2002; 4: Suppl s41-49.
5. Vogt PH. Molecular basis of male. (in)fertility. Int J Androl 1997; 20: Suppl3 2-10.
6. Vogt PH. Genetic disorders of human infertility In: Encyclopedia of the human genome online. (Cooper DC, Ed, nature publishing group; reference #520 in: http://ehgnaturereferencecom/ EHGheadwordshtm. 2003.
7. Stenchever MA, Macintyre MN, Jarvis JA, Hempel JM. Cytogenetic studies of 32 infertile couples. Obstet Gynecol 1969; 33: 380-382.
8. Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, et al. Cytogenetics of infertile men. Hum Reprod 1996; 11: 1-24.
9. Tournaye H, Staessen C, Liebaers I, Van Assche E, Devroey P, Bonduelle M, et al. Testicular sperm recovery in nine 47XXY Klinefelter patients Hum Reprod 1996; 11: 1644-1649.
10. Foss GL, Lewis FJ. A study of four cases with Klinefelter's syndrome showing motile spermatozoa in their ejaculates. J Reprod Fertil 1971; 25: 401-408.
11. Mroz K, Hassold TJ, Hunt PA. Meiotic aneuploidy in the XXY mouse: evidence that a compromised testicular environment increases in incidence meiotic errors. Hum Reprod 1999; 14: 1151-1156.
12. Rapley EA, Crockford GP, Tear D, Biggs P, Seal S, Barfoot R, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 2000; 24: 197-200.
13. Berthelsen JG, Skakkebaek NE, Perboll O, et al. Electron microscopic demonstration of the extra Y chromosome in spermatocytes from human XYY males. In Development and function of reproductive organs 1981; Byskov AG, Peters H, Eds, Excerpta Medica: Amsterdam pp 328-337.
14. Chandley AC, Gosden JR, Hargreave TB, Spowart G, Speed RM, McBeath S. Deleted Yq in the sterile son of a man with a satellited Y chromosome. (Yqa) J Med Gen 1989; 26: 145-153.
15. Vogt PH. Human Y chromosome function in male germ cell development. Adv Dev Biol 1996; 4: 191-257.
16. Fryns P, Kleczkowska A, Van den Berghe H. Clinical manifestation of Y/autosome translocations in man In Sandberg AA. (ed) The Y chromosome Part B: Clinical aspects of Y chromosome abnormalities. Alan R Liss Inc. New York. 1985; pp 213-243.
17. Smith A, Fraser IS, Elliot G. An infertile male with balanced Y;19 translocation Review of Y; autosome translocations. Ann Genet 1979; 22: 189-194
18. Gonzales J, Lesourd S, Dutrillaux B. Mitotic and meiotic analysis of a reciprocal translocation t(Y;3) in an azoospermic male. Hum Genet 1981; 57: 111-114.
19. Viguié F, Romani F, Dadoune JP. Male infertility in a case of (Y;6) balanced reciprocal translocation Mitotic and meiotic study. Hum Genet 1982; 62: 227.
20. Armstrong SJ, Kirkham AJ, Hulten MA. XY chromosome behaviour in the germ-line of the human male: a FISH analysis of spatial orientation chromatin concensation and pairing. Chromosome Res 1994; 2: 445-452.
21. Boucekkine C, Toublanc JE, Abbas N, Chaabouni S, Ouahid S, Semrouni M, et al. Clinical and anatomical spectrum in XX sex reversed patients Relationship to the presence of Y specific DNA-sequences. Clin Endocrin 1994; 40: 733-742.
22. Vogt PH. Genetic aspects of artificial fertilization. Hum Reprod 1995; 10: 128-137.
23. Zühlke C, This U, Braulke I. Down syndrome and male fertility: PCR-derived fingerprinting serological and andrological investigations. Clin Genet 1994; 46: 324-326.
24. Chaganti RSK, Jhanwar SC, Ehrenbard LT, Kourides IA, Williams JJ. Genetically determined asynapsis spermatogenic degeneartion and infertility in men. Am J Hum Genet 1980; 32: 833-848.
25. Egozcue S, Blanco J, Vendrell JM, Garcia F, Veiga A, Aran B, et al. Human male infertility: chromosome anomalies meiotic disorders abnormal spermatozoa and recurrent abortion. Hum Reprod Update 2000; 6: 93-105.
26. Faraut T, Mermet MA, Demongeot J, Cohen O. Cooperation of selection and meiotic mechanisms in the production of imbalances in reciprocal translocations. Cytogenetics and Cell Genetics 2000; 88: 15-21.
27. Finkelstein S, Mukamel E, Yavetz H, Paz G, Avivi L. Increased rate of nondisjunction in sex cells derived from low-quality semen. Hum Genet 1998; 102: 129-137.
28. Pfeffer J, Pang M-G, Hoegerman SF, Osgood CJ, Stacey MW, Mayer J, et al. Aneuploidy frequencies in semen fractions from ten oligoasthenoteratozoospermic patients donating sperm for intracytoplasmatic sperm injection. Fertil Steril 1999; 72: 472-478.
29. Pang MG, Hoegerman SF, Cuticchia AJ, Moon SY, Doncel GF, Acos AA, et al. Detection of aneuploidy for chromosomes 4 6 7 8 9 10 11 12 13 17 18 21 X and Y by fluorescence in-situ hybridization in spermatozoa from nine patients with oligoasthenoteratozoospermia undergoing intracytoplasmatic sperm injection. Hum Reprod 1999; 14: 1266-1273.
30. Vegetti W, Van Assche E, Frias A, Verheyen G, Bianchi MM, Bonduelle M, et al. Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men. Hum Reprod 2000; 15: 351-365.
31. Calogero AE, De Palma A, Grazioso C, Barone N, Romeo R, Rappazzo G, et al. Aneuploidy rate in spermatozoa of selected men with abnormal semen parameters. Hum Reprod 2001; 16: 1172-1179.
32. Shi Q, Martin RH. Multicolor fluorescence in situ hybridization analysis of meiotic chromosome segregation in a 47XYY male and a review of the literature. Am J Med Genet 2000; 93: 40-46.
33. Lewis-Jones I, Aziz N, Seshadri S, Douglas A, Howard P. Sperm chromosomal abnormalities are linked to sperm morphologic deformities. Fertil Steril 2003; 79: 212-215.
34. Silber S, Escudero T, Lenahan K, Abdelhadi I, Kilani Z, Munne S. Chromosomal abnormalities in embryos derived from testicular sperm extraction. Fertil Steril 2003; 79: 30-38.
35. Hassold T, Hunt P. To err. (meiotically) is human: the genesis of human aneuploidy. Genetic 2001; 2: 280-291.
36. Pieters MH, Geraedts JP, Meyer H, Dumoulin JC, Evers JL, Jongbloed RJ, et al. Human gametes and zygotes studied by nonradioactive in situ hybridisation. Cytogenet Cell Genet 1990; 53: 15-19.
37. Eils R, Uhrig S, Saracoglu K, Satzler K, Bolzer A, Petersen I, et al. An optimized fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (M-FISH). Cytogenet Cell Genet 1998; 82: 160-171.
38. Jorgensen AL. Alphoid repetitive DNA in human chromosomes. Dan Med Bull 1997; 44: 522-534.
39. Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, et al. Prenatel testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002; 17: 2600-2614.
40. Shi Q, Martin RH. Aneuploidy in human spermatozoa: FISH analysis in men with constitutional chromosomal abnormalities and in infertile men. Reproduction 2001; 121: 655-666.
41. Madgar I, Dor J, Weissenberg R, Raviv G, Menashe Y, Levron J. Prognostic value of the clinical and laboratory evaluation in patients with nonmosaic Klinefelter syndrome who are receiving assisted reproductive therapy. Fertil Steril 2002; 77: 1167-1169.
42. Rives N, Joly G, Machy A, Simeon N, Leclere P, Mace B. Assessment of sex chromosome aneuploidy in sperm nuclei from 47XXY and 46XY/47XXY males: comparison with fertil and infertile males with normal karyotype. Mol Hum Repod 2000; 6: 107-112.
43. Moosani N, Chernos J, Lowry RB, Martin RH, Rademaker A. A 47XXY fetus resulting from ICSI in a man with an elevated frequency of 24XY spermatozoa. Hum Reprod 1999; 14: 1137-1138.
44. Hennebicq S, Pelletier R, Bergues U, Rousseaux S. Risk of trisomy 21 in offspring of patients with Klinefelter's syndrome. Lancet 2001; 357: 2105.
45. Hassold T, Sherman S, Hunt P. Counting cross-overs: characterizing meiotic recombination in mammals. Hum Mol Genet 2000; 9: 2409-2419.
46. Metzler-Guillemain C, Guichaoua M-R. A simple and reliable method for meiotic studies on testicular samples used for intracytoplasmic sperm injection. Fertil Steril 2000; 74 916-919.
47. Armstrong SJ, Hultén MA. Meiotic segregation analysis by FISH investigations in sperm and spermatocytes of translocation heterozygotes. Europ J Human Genet 1998; 6: 430-431.
48. Makalowski W, Boguski MS. Evolutionary parameters of the transcribed mammalian genome: an analysis of 2820 orthologous rodent and human sequences. Proc Natl Acad Sci USA 1998; 95: 9407-9412.
49. Swanson WJ, Vacquier VD. The rapid evolution of reproductive proteins. Nat Rev Genet 2002; 3: 137-144.
50. Vogel F, Motulsky AG. Mutation. In Human genetics Springer-Verlag: Berlin 1986; pp 334-432.
51. Vogt PH. Human chromosome deletions in Yq11 AZF candidate genes and male infertility: history and update. Mol Hum Reprod 1998; 4: 739-744.
52. Krausz C, McElreavey K. Y chromosome and male infertility. Front Biosci 1999; 4: E1-8.
53. Oates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 1994; 15: 1-8.
54. Tiepolo L, Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 1976; 28: 119-124.
55. Reijo R, Alagappan RK, Patrizio P, Page DC. Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome. Lancet 1996; 347: 1290-1293.
56. Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors. (AZF) mapped to different subregions in Yq11. Hum Mol Genet 1996; 5: 933-943.
57. Kleiman SE, Yogev L, Gamzu R, Hauser R, Botchan A, Paz G, et al. Three-generation evaluation of Y-chromosome microdeletion. J Androl 1999; 20: 394-398.
58. Sant N, Terriou P, Navarro A, Levy N, Mitchell MJ. The human Y chromosome genes BPY2 CDY1 and DAZ are not essential for sustained fertility. Mol Hum Reprod 2000; 6: 789-793.
59. Calogero AE, Garofalo MR, Barone N, Longo GA, De Palma A, Fichera M, et al. Spontaneous transmission from a father to his son of a Y chromosome microdeletion involving the deleted in azoospermia. (DAZ) gene. J Endocrinol Invest 2002; 25: 631-634.
60. Pryor JL, Kent-First M, Muallem A, Van Bergen AH, Nolten WE, Meisner L, et al. Microdeletions in the Y chromosome of infertile men. N Engl J Med 1997; 20: 534-539.
61. Krausz C, Quintana-Murci L, McElreavey K. Prognostic value for Y deletion analyses: what is the clinical prognostic value of Y chromosome microdeletion analysis? Hum Reprod 2000; 15: 1431-1434.
62. Simoni M. Molecular diagnosis of Y chromosome microdeletions in Europe: state-of-the-art and quality control. Hum Reprod 2001; 16: 403-409.
63. Chen KS, Manian P, Koeuth T, Potocki L, Zhao Q, Chinault AC, et al. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet 1997; 17: 154-163.
64. Tilford CA, Kuroda-Kawaguchi T, Skaletsky H, Rozen S, Brown LG, Rosenberg M, et al. A physical map of the human Y chromosome. Nature 2001; 409: 943-945.
65. Kuroda-Kawaguchi T, Skaletzsky H, Brown LG, Minx PJ, Cordum H, Waterston RH, et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 2001; 29: 279-286.
66. Blanco P, Shlumukova M, Sargent CA, Jobling MA, Affara N, Hurles ME. Divergent outcomes of intrachromosomal recombination on the human Y chromosome: male infertility and recurrent polymorphism. J Med Genet 2000; 37: 752-758.
67. Kamp C, Hirschmann P, Voss H, Huellen K, Vogt PH. Two long homologous retroviral sequence blocks in proximal Yq11 cause AZFa microdeletions as a result of intrachromosomal recombination events. Hum Mol Genet 2000; 9: 2563-2572.
68. Sun C, Skaletsky H, Rozen S, Gromoll J, Nieschlag E, Oates R, et al. Deletion of azoospermia factor a. (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses Hum Mol Genet 2000; 9: 2291-2296
69. Repping S, Skaletsky H, Lange J, Silber S, Van Der Veen F, Oates RD, et al. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 2002; 71: 906-922.
70. Akgun E, Zahn J, Baumes S, Brown G, Liang F, Romanienko PJ, et al. Palindrome resolution and recombination in the mammalian germ line. Mol Cell Biol 1997; 17: 5559-5570.
71. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997; 278: 675-679.
72. Vogt PH, Affara N, Davey P, Hammer M, Jobling MA, Lau Y-FC, et al. Report on the third international workshop on Y chromosome mapping 1997. Cytogenetics and Cell Genetics 1997; 79: 1-20.
73. Murphy WJ, Sun S, Chen ZQ, Pecon-Slattery J, O'Brien SJ. Extensive conservation of sex chromosome organization between cat and human revealed by parallel radiation hybrid mapping. Genome Res 1999; 9: 1223-1230.
74. Quresbi SJ, Ross AR, Ma K, Cooke HJ, Intyre MA, Chandley AC, et al. Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically-determined spermatogenic failure in men. Mol Hum Reprod 1996; 2: 775-779.
75. Foresta C, Ferlin A, Garolla A, Rossato M, Barbaux S, De Bortoli A. Y-chromosome deletions in idiopathic severe testiculopathies. J Clin Endocrinol Metab 1997; 82: 1075-1080.
76. Luetjens CM, Gromoll J, Engelhardt M, Von Eckardstein S, Bergmann M, Nieschlag E, et al. Manifestation of Y-chromosomal deletions in the human testis: a morphometrical and immunohistochemical evaluation. Hum Reprod 2002; 17: 2258-2266.
77. Ferlin A, Moro E, Rossi A, Dallapiccola B, Foresta C. The human Y chromosome's azoospermia factor b. (AZFb) region: sequence structure and deletion analysis in infertile men. J Med Genet 2003; 40: 18-24.
78. Xu J, Burgoyne S, Arnord AP. Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet 2002; 11: 1409-1419.
79. Mahadevaiah SK, Odorisio T, Elliott DJ, Rattigan A, Szot M, Laval SH, et al. Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities. Hum Mol Genet 1998; 7: 715-727.
80. Elliott DJ, Millar MR, Oghene K, Ross A, Kiesewetter F, Pryor J, et al. Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci USA 1997; 94: 3848-3853.
81. Mazeyrat S, Saut N, Grigoriev V, Mahadevaiah SK, Ojarikre OA, Rattigan A, et al. A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis. Nat Genet 2001; 29: 49-53.
82. Gogarten JP, Olendzenski L. Orthologs paralogs and genome comparisons. Curr Opin Genet Dev 1999; 9: 630-636.
83. Shan Z, Hirschmann P, Seebacher T, Edelmann A, Jauch A, Morell J, et al. A SPGY copy homologous to the mouse gene Dazla and the Drosophila gene boule is autosomal and expressed only in the human male gonad. Hum Mol Genet 1996; 5: 2005-2011.
84. Seboun E, Barbaux S, Bourgeron T, Nishi S, Agulnik A, Egashira M, et al. Gene sequence localization and evolutionary conservation of DAZLA a candidate male sterility gene. Genomics 1997;41: 227-235.
85. Lahn BT, Page DC. Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome. Nat Genet 1999; 21: 429-433.
86. Sun C, Skaletsky H, Birren B, Devon K, Tang Z, Silber S, et al. An azoospermic man with a de novo point mutation in the Y-chromosome gene USP9Y. Nat Genet 1999; 23: 429-432.
87. Rolf C, Gromoll J, Simoni M, Nieschlag E. Natural transmission of a partial AZFb deletion of the Y chromosome over three generations: case report. Hum Reprod 2002; 17: 2267-2271.
88. Prosser J, Inglis JD, Condie A, Ma K, Kerr S, Thakrar R, et al. Degeneracy in human multicopy RBM. (YRRM) a candidate spermatogenesis gene. Mamm Gcnome 1996; 7: 835-842.
89. Fernandes S, Huellen K, Goncalves J, Dukal H, Zeisler J, Rajpert De Meyts E, et al. High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. Mol Hum Reprod 2002; 8: 286-298.
90. Stuppia L, Calabrese Q, Franchi PG, Mingarelli R, Gatta V, Palka G, et al. Widening of a Y-chromosome inteval-6 deletion transmitted from a father to his infertile son accounts for an oligozoospermia criterial region distal to the RBM1 and DAZ genes. Am J Hum Genet 1996; 59: 1393-1395.
91. MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 921-923.
92. Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000a; 95: 1100-1105.
93. Vogt HHJ, van den Muijsenberg JW, Goulmy E, Spierings E, Kluck P, Kester MG, et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002; 99: 3027-3032.
94. Vogt MHJ, Goulmy E, Kloosterboer FM, Blokland E, de Paus RA, Willemze R, et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000b; 96: 3126-3132.
95. Warren EH, Gavin MA, Simpson E, Chandler P, Page DC, Disteche C, et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immumol 2000; 164: 2807-2814.
96. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 1588-1590.
97. Meadows L, Wang W, den Haan JM, Blokland E, Reinhardus C, Drijfhout JW, et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally- modified cysteine that significantly affects T cell recognition. Immunity 1997; 6: 273-281.
98. Ohno S, Nagai Y, Ciccarese S, Iwata H. Testis-organizing H-Y antigen and the primary sex-determining mechanism of mammals. Recent Prog Horm Res 1997; 35: 449-476.
99. O'Reilly AJ, Affara NA, Simpson E, Chandler P, Goulmy E, Ferguson-Smith MA. A molecular deletion map of the Y chromosome long arm defining X and autosomal homologous regions and the localisation of the HYA locus to the proximal region of the Yq euchromatin. Hum Mol Genet 1992; 1: 379-385.
100. Goldberg EH. H-Y antigen and sex determination. Philos Trans R Soc B Biol Sci 1988; 322: 73-81.
101. Kent-First MG, Kol S, Muallem A, Ofir R, Manor D, Blazer S, et al. The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathers. Mol Hum Reprod 1996; 2: 943-950.
102. Page DC, Silber S, Brown LG. Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection but are likely to transmit the deletion and infertility. Hum Reprod 1999; 14: 1722-1726.
103. Oates RD, Silber S, Brown LG, Page DC. Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome and of 18 children conceived via ICSI. Hum Reprod 2002; 17: 2813-2824.
104. Siffroi JP, Bourhis C, Krausz C, Barbaux S, Quintana-Murci L, Kanafani S, et al. Sex chromosome mosaicism in males carrying Y chromosome long arm deletions. Hum Reprod 2000; 15: 2559-2562.
105. Jaruzelska J, Korcz A, Wojda A, Jedrzejczak P, Bierla J, Surmacz T, et al. Mosaicism for 45X cell line may accentuate the severity of spermatogenic defects in men with AZFc deletion. J Med Genet 2001; 38: 798-802.
106. Papadimas J, Goulis DG, Giannouli C, Papanicolaou A, Tarlatzis B, Bontis JN. Ambiguous genitalia 45X/46XY mosaic karyotype and Y chromosome microdeletions in a 17-year-old man. Fertil Steril 2001; 76: 1261-1263.
107. Patsalis PC, Sismani C, Quintana-Mursi L, Taleb-Bekkouche F, Krausz C, McElreavey K. Effects of transmission of Y chromosome AZFc deletions. Lancet 2002; 360: 1222-1224.
108. Chang HJ, Clark RD, Bachman H. The phenotype of 45X/46XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet 1990; 46: 156-167.
109. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization, of complementary DNA. Science 1989; 245: 1066-1073.
110. Haardt M, Benharouga M, Lechardeur D, Kartner N, Lukacs GL. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis A novel class of mutation. J Biol Chem 1999; 274: 21873-21877.
111. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum Mutat 2002; 19: 575-606.
112. Estivill X. Complexity in a monogenic disease. Nature Genet 1996; 12: 348-50.
113. Girodon E, Cazeneuve C, Lebargy F, Chinet T, Costes B, Ghanem N, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997; 5: 149-155.
114. Pier GB. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection. Curr Opin Microbiol 2002; 5: 81-86.
115. Jarvi K, Zielenski J, Wilschanski M, Durie P, Buckspan M, Tullis E, et al. Cystic fibrosi: transmembrane conductance regulator and obstructive azoospermia. Lancet 1995; 345: 1578.
116. Hargreave TB. Genetic basic of male fertility. Br Med Bull 2000 56: 650-671.
117. Kiesewetter S, Macek M Jr, Davis C, Curristin SM, Chu CS, Graham C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5: 274-278.
118. Zielenski J, Patrizio P, Corey M, Handelin B, Markiewicz D, Asch R, et al. CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet 1995; 57: 958-960.
119. Patrizio P, Asch RH, Handelin B, Silber SJ. Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum Reprod 1993; 8: 215-220.
120. Cuppens H, Teng H, Raeymaekers P, De Boeck C, Cassiman JJ. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 1994; 3: 607-614.
121. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. J Clin Invest 1998; 101: 487-496.
122. Teng H, Jorissen M, Van Poppel H, Legius E, Cassiman JJ, Cuppens H. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet 1997; 6: 85-90.
123. Ferrie RM, Schwarz MJ, Robertson NH, Vaudin S, Super M, Malone G, et al. Development multiplexing and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 1992; 51: 251-262.
124. Fonknechten N, Chelly J, Lepercq J, Kahn A, Kaplan JC, Kitzis A, et al. CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts. Hum Genet 1992; 88: 508-512.
125. Dequeker E, Cassiman JJ. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment. Eur J Hum Genet 1998; 6: 165-175.
126. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis. Eur J Hum Genet 2000; 8: Suppl 2 S2-24.
127. von Eckardstein S, Cooper TG, Rutscha K, Meschede D, Horst J, Nieschlag E. Seminal plasma characteristics as indicators of cystic fibrosis transmembrane conductance regulator. (CFTR) gene mutation in men with obstructive azoospermia. Fertil Steril 2000; 73: 1226-1231.
128. Suarez-Quian CA, Martinez-Garcia F, Nistal M, Regadera J. Androgen receptor distribution in adult human testis. J Clin Endocrinol Metab 1999; 84: 350-358.
129. Heinlein AA, Chang C. Androgen receptor. (AR) coregulators: an overview. Endocr Rev 2002; 23: 175-200.
130. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation impaired sperm production and male infertility. J Clin Endocrinol Metab 1997; 82: 3777-3782
131. Patrizio P, Leonard DG, Chen KL, Hernandez-Ayup S, Trounson AO. Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl 2001; 22: 444-448.
132. Casella R, Maduro MR, Misfud A, Lipshultz LI, Yong EL, Lamb DJ. Androgen receptor gene polyglutamine length is associated with testicular histology in infertile patients. J Urol 2003; 169: 224-227.
133. Hiort O, Holterhus P-M. Androgen insensitivity and male infertility. Int J Androl 2003; 26: 16-20.
134. Rajpert-De Meyts E, Leffers H, Petersen JH, Andersen AG, Carlsen Jorgensen N, Skakkebaek NE. CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 2002; 5: 44-46.
135. Dadze S, Wieland C, Jakubiczka S, Funke K, Schroder E, Royer-Pokora B, et al. The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin. Mol Hum Repod 2000; 6: 207-214.
136. Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Sing L. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl 2002; 23: 815-818.
137. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77-79.
138. Yong EL, Lim LS, Wang Q, Mifsud A, Lim J, Ong YC, et al. Androgen receptor polymorphisms and mutations in male infertility. J Endocrinol Invest 2000; 23: 573-577.
139. Yong EL, Ng SC, Roy AC, Yun G, Ratnam SS. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene Lancet 1994; 344: 826-827.
140. Grewal RP, Leeflang EP, Zhang L, Arnheim N. The mutation properties of spinal and bulbar muscular atrophy disease alleles. Neurogenetics 1998; 1: 249-252.
141. Vogt PH. Risk of neurodegenerative diseases in children conceived by intracytoplasmatic sperm injection? Lancet 1999; 354: 611-612
142. Aittomaki K. FSH receptor defects and reproduction. In Fertility and Reproductive Medicine 1998; Kempers RD, Cohen J, Haney AF, Younger JB Eds, Elsevier Science BV: Amsterdam pp 761-788.
143. Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone. (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997; 15: 205-206.
144. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 2000; 141: 1795-1803.
145. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002; 8: 413-421.
146. Sultan C, Lumbroso S. LH receptor defects. In Fertility and Reproductive Medicine Kempers RD, Cohen J, Haney AF, Younger JB Eds, Elsevier Science BV: Amsterdam 1998; pp 769-782.
147. Kremer H, Mariman E, Otten BJ, Moll GW Jr, Stoelinga GB, Wit JM, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 1993; 2: 1779-1783.
148. Achermann JC, Weiss J, Lee EJ, Jameson JL. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 2001; 179: 89-96.
149. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991; 353: 529-536.
150. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991; 67: 423-435.
151. Del Castillo I, Cohen-Salmon M, Blanchard S, Lutfalla G, Petit C. Structure of the X-linked Kallmann syndrome gene and its homologous pseudogene on the Y chromosome. Nat Genet 1992; 2: 305-310.
152. Bulow HE, Berry KL, Topper LH, Peles E, Hobert O. Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc Natl Acad Sci USA 2002; 99: 6346-6351.
153. Hardelin JP. Kallmann syndrome: towards molecular pathogenesis. Mol Cell Endocrinol 2001; 179: 75-81.
154. Hardelin JP, Levilliers J, del Castillo I, Cohen-Salmon M, Legouis R, Blanchard S, et al. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci USA 1992; 89: 8190-8194.
155. Bick D, Franco B, Sherins RJ, Heye B, Pike L, Crawford J, et al. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med 1992; 326: 1752-1755.
156. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33: 463-465.
157. Quinton R, Duke VM, de Zoysa PA, Platts AD, Valentine A, Kendall B, et al. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 1996; 81: 3010-3017.
158. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest 1996; 98: 1055-1062.
159. Seminara SB, Oliveira LM, Beranova M, Hayes FJ, Crowley WF Jr. Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest 2000; 23: 560-565.
160. Rott HD. Kartagener's syndrome and the syndrome of immotile cilia. Hum Genet 1979; 46: 249-261.
161. Afzelius BA, Mossberg B. The metabolic and molecular bases of inherited disease. Scriver CR, Beaudet AL and Sly WS, Eds, McGraw-Hill: New York 1995; pp 3943-3954..
162. Samuel I. Kartagener's syndrome with normal spermatozoa. JAMA 1987; 258: 1329-1330.
163. Narayan D, Krishnan SN, Upender M, Ravikumar TS, Mahoney MJ, Dolan TF Jr, et al. Unusual inheritance of primary ciliary dyskinesia. (Kartagener's syndrome). J Med Genet 1994; 31: 493-496.
164. Blouin JL, Meeks M, Radhakrishna U, Sainsbury A, Gehring C, Sail GD, et al. Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive, locus heterogeneity. Eur J Hum Genet 2000; 8: 109-118.
165. Pennarun G, Escudier E, Chapelin C, Bridoux AM, Cacheux V, Roger G, et al. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet 1999; 65: 1508-1519.
166. Olbrich H, Haffner K, Kispert A, Volkel A, Volz A, Sasmaz G, et al. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat Genet 2002; 30: 143-144.
167. Bartoloni L, Blouin J-L, Pan Y, Gehrig C, Maiti AK, Scamuffa N, et al. Mutations in the DNAH 11. (axonemal heavy chain dynein type 11) gene cause form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci USA 2002; 99: 10282-10286.
168. Dutcher SK. Flagellar assembly in two hundred and fifty easy-to-follow steps. Trends 1995; 11: 389-404.
169. Florke-Gerloff S, Topfer-Petersen E, Muller-Esterl W, Mansouri A, Schatz R, Schirren C, et al. Biochemical and genetic investigation of round-headed spermatozoa in infertile men including two brothers and their father, Andrologia 1994; 16: 187-202.
170. Singh G. Ultrastructural features of round-headed human spermatozoa. Int J Fertil 1992; 37: 99-102.
171. Carrell DT, Emery BR, Liu L. Characterization of aneuploidy rates protamine levels ultrastructure and functional ability of round-headed sperm from two siblings and implications for intracytoplasmic sperm injection. Fertil Steril 1999; 71: 511-516.
172. Carrell DT, Liu L. Altered protamine 2 expression is uncommon in donors of known fertility but common among men with poor fertilizing capacity and may reflect other abnormalities of spermiogenesis. J Androl 2001; 22: 604-610.
173. Carrell DT, Wilcox AL, Udoff LC, Thorp C, Campbell B. Chromosome 15 aneuploidy in the sperm and conceptus of a sibling with variable familial expression of round-headed sperm syndrome. Fertil Sertil 2001; 76: 1258-1260.
174. Viville S, Mollard R, Bach ML, Falquet C, Gerlinger P, Warter S. Do morphological anomalies reflect chromosomal aneuploidies?: Case report. Hum Reprod 2000; 15: 2563-2566.
175. Vicari E, Perdichizzi A, De Palma A, Burrello N, D'Agata R, Calogero AE. Globozoospermia is associated with chromatin structure abnormalities: case report. Hum Reprod 2002; 17: 2128-2133.
176. Sakkas D, Urner F, Bizarre D, Manicardi G, Bianchi PG, Shoukir Y, et al. Sperm nuclear DNA damage and altered chromatin structure: effect on fertilization and embryo development. Hum Reprod 1998; 13: Suppl 4 11-19.
177. Adham IM, Emmen JM, Engel W. The role of the testicular factor INSL3 in establishing the gonadal position. Mol Cell Endocrinol 2000; 160: 11-16.
178. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet 1999; 22: 295-299.
179. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF. Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 2000; 85: 4013-4018.
180. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, et al. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent J Biol Chem 2002; 277: 31283-31286.
181. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, et al. Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 2002; 11: 2309-2318.
182. Moreno-Garcia M, Miranda EB. Chromosomal anomalies in cryptorchidism and hypospadias. J Urol 2002; 168: 2170-2172.
183. Groenen P and Wieringa B. Expanding complexity in myotonic dystrophy. BioEssay 1998; 20: 901-912.
184. Takeda R, Ueda M. Pituitary-gonadal function in male patients with myotonic dystrophy- serum luteinizing hormone follicle stimulating hormone and testosterone levels and histological dmaage of the testis. Acta Endocrinol. (Copenh) 1977; 84: 382-389.
185. Hortas ML, Castilla JA, Gil MT, Molina J, Garrido ML, Morell M, et al. Decreased sperm function of patients with myotonic muscular dystrophy. Hum Reprod 2000; 15: 445-448.
186. Zullo SJ, Butler L, Zahorchak RJ, Macville M, Wilkes C, Merril CR. Localization by fluorescence in situ hybridization. (FISH) of human mitochondrial polymerase gamma. (POLG) to human chromosome band 15q24→q26 and of mouse mitochondrial polymerase gamma. (Polg) to mouse chromosome band 7E with confirmation by direct sequence analysis of bacterial artificial chromosomes. (BACs) Cytogenet Cell Genet 1997; 78: 281-284.
187. Rovio A, Tiranti V, Bednarz AL, Suomalainen A, Spelbrink JN, Lecrenier N, et al. Analysis of the trinucleotide CAG repeat from the human mitochondrial DNA polymerase gene in healthy and diseased individuals. Eur J Hum Genet 1999; 7: 140-146.
188. Rovio AT, Marchington DR, Donat S, Schuppe H-C, Abel J, Fritsche E, et al. Mutations at the mitochondrial DNA polymerase. (POLG) locus associated with male infertility. Nature Genetics 2001; 29: 261-262.
189. Kao SH, Chao HT, Wei YH. Mitochondrial dcoxyribonuclei acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biology of Reproduction 1995; 52: 729-736.
190. Kao SH, Chao HT, Wei YH. Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Mol Hum Reprod 1998; 4: 657-666.
191. St John JC, Jokhi RP, Barratt CL. Men with oligoasthenoteratozoospermia harbour higher numbers of multiple mitochondrial DNA deletions in their spermatozoa but individual deletions are not indicative of overall actiology. Mol Hum Reprod 2001; 7: 103-111.
192. O'Connell M, McClure N, Lewis SE. A comparison of mitochondrial and nuclear DNA status in testicular sperm from fertile men and those with obstructive azoospermia. Hum Reprod 2002; 17: 1571-1577.
193. Ruiz-Pesini E, Lapena A, Diez-Sanchez C, Perez-Martos A, Enriquez J, Diaz M, et al. Human mitochondrial DNA haplogroups associated with high or reduced spermatozoa motility: Am J Hum Genet 2000; 67: 682-696.
194. Cummins JM, Jequier AM, Kan R. Molecular biology of human male infertility: Links with aging mitochondrial genetics and oxidative stress? Mol Reprod Dev 1994; 37: 345-362.
195. Wolf U. The genetic contribution to the phenotype. Hum Genet 1995; 95: 127-148.
196. Badano JL, Katsanis N. Beyond mendel: an evolving view of human genetics disease transmission. Nature Genet 2002; 3: 779-789.
197. Friel A, Houghton JA, Glennon M, Lavery R, Smith T, Nolan A, et al. A preliminary report on the implication of RT-PCR detection of DAZ RBMY1 USP9Y and Protamine-2 mRNA in testicular biopsy samples from azoospermic men. Int J Androl 2002; 25: 59-64.
198. Lin YM, Chen CW, Sun HS, Tsai SJ, Hsu CC, Teng YN, et al. Expression patterns and transcript concentrations of the autosomal DAZL gene in testes of azoospermic men. Mol Hum Reprod 2001; 7: 1015-1022.
199. Behr R, Weinbauer GF. cAMP response element modulator. (CREM): an essential factor for spermatogenesis in primates? Int J Androl 2001; 24: 126-135.
200. Kleiman SE, Lagziel A, Yogev L, Botchan A, Paz G, Yavetz H. Expression of CDY1 may identify complete spermatogenesis. Fertil Steril 2001; 75: 166-173.
201. Hauser R, Botchan A, Yogev L, Gamzu R, Ben Yosef D, Lessing JB, et al. Probability of sperm detection in nonobstructive azoospermic men undergoing testicular sperm extraction procedures unrelated to clinical parameters. Arch Androl 2002; 48: 301-305.
202. Vernaeve V, Tournaye H, Schiettecatte J, Verheyen G, Van Steirteghem A, Devroey P. Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia. Hum Reprod 2002; 17: 971-976.
203. Venables JP, Eperon I. The roles of RNA-binding proteins in spermatogenesis and male infertility. Curr Opin Genet Dev 1999; 9::346-54.
204. Xu EY, Moore FL, Pera RA. A gene family required for human germ cell development evolved from an ancient meiotic gene conserved in metazoans. Proc Natl Acad Sci USA 2001; 98: 7414-7419.
205. Grossmann B, Weinbauer G, Hirschmann P, Vogt PH. Conservation of the deleted-in-azoospermia-like-1. (DAZL1) gene structure in old world monkeys points to a homologous function of DAZL1 in this primate class. J Endocrinol Invest 2000; 23: 616-622.
206. Lin YM, Chen CW, Sun HS, Tsai SJ, Lin JS, Koo PL. Presence of DAZL transcript and protein in mature human spermatozoa. Fertil Steril 2002; 77: 626-629.
207. Habermann B, Mi HF, Edelmann A, Bohring C, Backert IT, Kiesewetter F, et al. DAZ. (Deleted in AZoospermia) genes encode proteins located in human late spermatids and in sperm tails. Hum Reprod 1998; 13: 363-369.
208. Walker HW, Habener JF. Role of transcription factors CREB and CREM in cAMP-regulated transcription during spermatogenesis. Trends Endocrinol Metab 1996; 7: 133-138.
209. Masquilier D, Foulkes NS, Mattei MG, Sassone-Corsi P. Human CREM gene: evolutionary conservation chromosomal localization and inducibility of the transcript. Cell Growth Differ 1993; 4: 931-937.
210. Foulkes NS, Mellstrom B, Benusiglio E, Sassone-Corsi P. Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature 1992; 355: 80-84.
211. Peri A, Serio M. The CREM system in human spermatogenesis. J Endocrinol Invest 2000; 23: 578-583.
212. Gellersen B, Kempf R, Sandhowe R, Weinbauer GF, Behr R. Novel leader exons of the cyclic adenosine 3′5′-monophosphate response element modulator. (CREM) gene transcribed from promoters P3 and P4 are highly testis-specific in primates. Mol Hum Reprod 2002; 8: 965-976.
213. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER an early response repressor. Cell 1993; 75: 875-886.
214. Fimia GM, De Cesare D, Sassone-Corsi P. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature 1999; 398: 165-169.
215. Weinbauer GF, Behr R, Bergmann M, Nieschlag E. Testicular cAMP responsive element modulator. (CREM) protein is expressed in round spermatids but is absent or reduced in men with round spermatid maturation arrest. Mol Hum Reprod 1998; 4: 9-15.
216. Steger K. Transcriptional and translational regulation of gene expression in haploid spermatids. Anat Embryol 1999; 199: 471-487.
217. Song GJ, Lee H, Park Y, Lee HJ, Lee YS, Seo JT, et al. Expression pattern of germ cell-specific genes in the testis of patients with nonobstructive azoospermia: usefulness as a molecular marker to predict the presence of testicular sperm Fertil Steril 2000; 73: 1104-1108.
218. Lahn BT, Tang ZL, Zhou J, Barndt RJ, Parvinen M, Allis CD, et al. Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis. Proc Natl Acad Sci USA 2002; 99: 8707-8712.
219. Meistrich ML, Trostle-Weige PK, Lin R, Bhatnagar YM, Allis CD. Highly acetylated H4 is associated with histone displacement in rat spermatids. Mol Reprod Dev 1992; 31: 170-181.
220. Krausz C, Quintana-Murci L, Rajpert-De Meyts E, Jorgensen N, Jobling MA, Rosser ZH, et al. Identification of a Y chromosome haplogroup associated with reduced sperm counts. Hum Mol Genet 2001; 10: 1873-1877.
221. Krausz C, Rajpert-De Meyts E, Frydelund-Larsen L, Quintana-Murci L, McElreavey K, Skakkebaek NE. Double-blind Y chromosome microdeletion analysis in men with known sperm parameters and reproductive hormone profiles: microdeletions are specific for spermatogenic failure. J Clin Endocrinol Metab 2001; 86: 2638-2642.
222. Simoni M, Bakker E, Eurlings MC, Matthijs G, Moro E, Muller CR, et al. Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl 1999; 22: 292-299.
223. Kamp C, Huellen K, Fernandes S, Sousa M, Schlegel PN, Mielnik A, et al. High deletion frequency of the complete AZFa sequence in men with Sertoli-celi-only syndrome. Mol Hum Reprod 2001; 7: 987-994.
224. Tournaye H. Surgical sperm recovery for intracytoplasmatic sperm injection which method is to be preferred? Hum Reprod 1999; 14: Suppl 171-81.
225. Bukulmez O, Yucel A, Yarali H, Bildirici I, Gurgan T. The origin of spermatozoa does not affect intracytoplasmic sperm injection outcome. Eur J Obstet Gynecol Reprod Biol 2001; 94: 250-255.
226. Ubaldi F, Nagy ZP, Rienzi L, Tesarik J, Anniballo R, Franco G, et al. Reproductive capacity of spermatozoa from men with testicular failure. Hum Reprod 1999; 14: 2796-2800.
227. Pasqualotto FF, Rossi-Ferragut LM, Rocha CC, Iaconelli Jr A, Borges Jr E. Outcome of in vitro fertilization and intracytoplasmic injection of epididymal and testicular sperm obtained from patients with obstructive and nonobstructive azoospermia. J Urol 2002; 167: 1753-1756.
228. Kirchhoff C. Gene expression in the epididymis. Int Rev Cytol 1999; 188: 133-202.
229. Kirchhoff C. The dog as a model to study human epididymal function at a molecular level. Mol Hum Reprod 2002; 8: 695-701.
230. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999; 285: 1393-1396.
231. Kelner MJ, Montoya MA. Structural organization of the human selenium-dependent phospholipid hydroperoxide glutathione peroxidase gene. (GPX4): chromosomal localization to 19p133. Biochem Biophys Res Commun 1998; 249: 53-55.
232. Foresta C, Flohé L, Garolla A, Roveri A, Ursini F, Maiorino M. Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol Reprod 2002; 67: 967-971.
233. Balhorn R, Reed S, Tanphaichitr N. Aberrant protamine 1/protamine 2 ratios in sperm of infertile human males. Experientia 1988; 44: 52-55.
234. Cho C, Willis WD, Goulding EH, Jung-Ha H, Choi YC, Hecht NB, et al. Haploinsufficiency of protamine-1 or -2 causes infertility in mice. Nat Genet 2001; 28: 82-86.
235. Cho C, Jung-Ha H, Willis WD, Goulding EH, Stein P, Xu Z, et al. Protamine-2 deficiency leads to sperm.DNA damage and embryo death in mice. Biol Reprod 2003; 68: (5) [in press].
236. Belokopytova IA, Kostyleva EI, Tomilin AN, Vorob'ev VI. Human male infertility may be due to a decrease of the protamine P2 content in sperm chromatin. Mol Reprod Dev 1993; 34: 53-57.
237. Sutovsky P, Terada Y, Schatten G. Ubiquitin-based sperm assay for the diagnosis of male factor infertility. Hum Reprod 2001a; 16: 250-258.
238. Sutovsky P, Moreno R, Ramalho-Santos J, Dominko T, Thompson WE, Schatten G. A putative ubiquitin-dependent mechanism for the recognition and elimination of defective spermatozoa in the mammalian epididymis. J Cell Sci 2001b; 114: 1665-1675.
239. Brinster RL. Germline stem cell transplantation and transgenesis. Science 2002; 296: 2174-2176.
240. Nagano M, Patrizio P, Brinster RL. Long-term survival of human spermatogonial stem cells in mouse testes. Fertil Steril 2002; 78: 1225-1233.
241. Wyckoff GJ, Wang W, Wu CI. Rapid evolution of male reproduction genes in the descent of man. Nature 2000; 403: 304-309.
242. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346: 725-730.
243. De Rycke M, Liebaers I, Van Steirteghem A. Epigenetic risks related to assisted reproduction technologies. Hum Reprod 2002; 17: 2487-2494.
244. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346: 731-737.
245. Cox GF, Bürger J, Lip V, Mau UA, Sperling K, Wu B-L, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Human Genet 2002; 71: 162-164.
246. Nicholls RD, Knepper JL. Genome organization function and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2001; 2: 153-175.
247. DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum. Genet.2003; 72: 156-160.
248. Koshla S, Dean W, Reik W, Feil R. Epigenetic and experimental modifications in early mammalian development: Part II Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Hum Reprod Update 2001; 7: 419-427.
249. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003; 423: 825-837.
250. Hackney AC. Endurance exercise training reproductive endocrine dysfunction in men: alterations in the hypothalamic-pituitary-testicular axis. Curr Pharm Design 2001; 7(4): 261-73.
251. Haney SA, Alksne LE, Dunman PM, Murph E, Projan SJ. Genomics in anti-infective drug discovery - getting to endgame. Cuff Pharm Design 2002; 8(13): 1099-118.
252. Machado AF, Martin LJ, Collins MD. Pax3 and the splotch mutations: structure, function, and relationship to teratogenesis, including gene-chemical interactions. Curr Pharm Design 2001; 7(9): 751-85.